晚期卵巢癌的CT与MRI:影像技术进展
晚期卵巢癌以腹膜腔播散为主,标准治疗包括肿瘤细胞减灭术、铂类化疗及根据基因分型的靶向维持治疗。增强CT是分期金标准但检出小体积腹膜播散能力有限,MRI以软组织对比优势补充评估腹膜病变,扩散加权成像和钆增强MRI提高了腹膜病变诊断敏感度但无法预测治疗反应、复发风险与预后,影像组学有望用于个体化治疗和识别早期复发风险患者。
要点
- 增强CT是晚期卵巢癌分期和评估肿瘤范围的金标准,可识别腹膜、淋巴及远处转移。
- CT对检出小体积腹膜播散效果较差,MRI软组织对比更优可补充评估腹膜病变。
- 扩散加权成像和钆增强MRI提高了腹膜病变诊断敏感度,但无法预测治疗反应、复发风险与预后。
核心结论
- 整合CT、MRI与影像组学可能改善晚期卵巢癌的手术规划并提高长期生存结局;约25%的高级别浆液性卵巢癌患者在初次治疗达到完全肿瘤清除后一年内复发。
研究设计与样本
- 综述,围绕晚期卵巢癌的增强CT、MRI及影像组学等影像技术进展进行阐述。
关键影像表现/征象
- 增强CT可有效识别腹膜、淋巴及远处转移,但对小体积腹膜播散检出效果较差。
- MRI软组织对比更优,可详细评估腹膜病变,并表征超声不确定的附件肿块。
- 扩散加权成像和钆增强MRI提高了腹膜病变的诊断敏感度。
局限性
- CT对检出小体积腹膜播散效果较差。
- 扩散加权成像和钆增强MRI无法预测治疗反应、复发风险与预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ovarian cancer (OC) remains one of the leading causes of gynecologic cancer-related mortality, with most patients presenting with disseminated disease, particularly within the peritoneal cavity. Standard treatment includes cytoreductive surgery, platinum-based chemotherapy, and targeted maintenance approaches depending on the patient's and tumor's genetic profile. Despite treatment advancements, approximately 25% of high-grade serous OC cases relapse within a year despite optimal primary treatment with complete tumor clearance at cytoreduction. Advances in contrast-enhanced CT (CE-CT) and MRI have revolutionized the evaluation and treatment planning of advanced OC. CT remains the gold standard for staging and assessing tumor extent, effectively identifying peritoneal, lymphatic, and distant metastases. However, it is less effective in detecting small-volume peritoneal dissemination. MRI, with superior soft-tissue contrast, complements CT by providing a detailed assessment of peritoneal disease, characterizing sonographically indeterminate adnexal masses. Diffusion-weighted imaging and gadolinium-enhanced MRI have improved the diagnostic sensitivity for peritoneal disease but are unable to predict treatment response, recurrence risk, and prognosis. Radiomics, which extracts quantitative tumor features from imaging data, holds promise for personalizing treatment and identifying patients at risk for early recurrence despite optimal therapy. The integration of CT, MRI, and radiomics could enhance surgical planning and improve long-term survival outcomes in patients with advanced OC.
引用
- Chiu S, Tsitsiou Y, Da Silva A, et al. CT and MRI in Advanced Ovarian Cancer: Advances in Imaging Techniques. Korean J Radiol. 2025. PMID: 40873375. doi:10.3348/kjr.2025.0357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。